Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 196 participants.
Also called NCT04014023
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 196 participants
- Registry
-
NCT04014023
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04014023. Randomized; double masking; primary purpose treatment. Start 2019-07-10 (actual); primary completion 2020-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
- Condition
- T2DM (Type 2 Diabetes Mellitus)
- Intervention (Drug)
- DWP16001
- Intervention (Drug)
- Placebo
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct04014023- Content hash
f17714d4395aa7ca10a3f57ff08ace8a9d24a340d76c890d10561ecd9721d9d7